end of april, page-47

Cujo

I agree that the Lenstec lens is doing poorly. Since the trials have finished it has never been a popular product. As per the recorded royalties. I would be surprised if Lenstec is picked up. I've rang the US number and no one seems to know anything. I've spoken to a lenstec rep in brisbane and she doesn't know anything either. (I wouldn't really expect them to advertise it but has anyone heard anything of substance?)Given the sales figures, and how the lense isn't a popular choice post trails I'm having trouble seeing how it will evolve under the arm of Alcon and why they would want it.


However, like i wrote lets see what happens with trisense.
Perhaps there is a deal in the wind time will tell. Or perhaps TA will tell. Currently there is at least two products that i can think of that are used in surgery and ithey are $2000 a dose! Both these products aren't Alcons, maybe TA figures will be worth the wait?